BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25155421)

  • 1. Arterial chemoradiotherapy for carcinomas of the external auditory canal and middle ear.
    Fujiwara M; Yamamoto S; Doi H; Takada Y; Odawara S; Niwa Y; Ishikura R; Kamikonya N; Terada T; Uwa N; Sagawa K; Hirota S
    Laryngoscope; 2015 Mar; 125(3):685-9. PubMed ID: 25155421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin.
    Nakagawa T; Kumamoto Y; Natori Y; Shiratsuchi H; Toh S; Kakazu Y; Shibata S; Nakashima T; Komune S
    Otol Neurotol; 2006 Feb; 27(2):242-8; discussion 249. PubMed ID: 16436996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The outcome of treatments for carcinoma of the external auditory canal].
    Schmerber S; Righini Ch; Soriano E; Delalande C; Dumas G; Reyt E; Lavieille JP
    Rev Laryngol Otol Rhinol (Bord); 2005; 126(3):165-70. PubMed ID: 16366384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoma of the external auditory canal and middle ear: therapeutic strategy and follow up].
    Kollert M; Draf W; Minovi A; Hofmann E; Bockmühl U
    Laryngorhinootologie; 2004 Dec; 83(12):818-23. PubMed ID: 15611900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the external auditory canal: histological and treatment groups.
    Hosokawa S; Mizuta K; Takahashi G; Okamura J; Takizawa Y; Hosokawa K; Yamatodani T; Mineta H
    B-ENT; 2014; 10(4):259-64. PubMed ID: 25654948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prognosis of squamous cell carcinoma of the external auditory canal and middle ear: a multi-institutional retrospective review of 87 patients.
    Ogawa K; Nakamura K; Hatano K; Uno T; Fuwa N; Itami J; Kojya S; Nakashima T; Shinhama A; Nakagawa T; Toita T; Sakai M; Kodaira T; Suzuki M; Ito H; Murayama S
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1326-34. PubMed ID: 17446002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.
    Koto M; Hasegawa A; Takagi R; Sasahara G; Ikawa H; Mizoe JE; Jingu K; Tsujii H; Kamada T; Okamoto Y;
    Head Neck; 2016 Apr; 38(4):512-6. PubMed ID: 25352333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
    Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
    Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: A meta-analysis.
    Takenaka Y; Cho H; Nakahara S; Yamamoto Y; Yasui T; Inohara H
    Head Neck; 2015 Jul; 37(7):1073-80. PubMed ID: 24692266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the external auditory canal and middle ear.
    Lin JC; Chen KY; Jan JS; Wu YP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jul; 8(7):358-65. PubMed ID: 1433440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.
    Prabhu R; Hinerman RW; Indelicato DJ; Morris CG; Werning JW; Vaysberg M; Amdur RJ; Kirwan J; Mendenhall WM
    Am J Clin Oncol; 2009 Aug; 32(4):401-4. PubMed ID: 19398900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoma of the external ear canal and middle ear as interdisciplinary challenge for ear surgery and radiotherapy].
    Schwager K; Pfreundner L; Hoppe F; Baier G; Willner J; Baier K
    Laryngorhinootologie; 2001 Apr; 80(4):196-202. PubMed ID: 11383121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-institutional Survey of Squamous Cell Carcinoma of the External Auditory Canal in Japan.
    Shiga K; Nibu KI; Fujimoto Y; Asakage T; Homma A; Mitani H; Ogawa T; Okami K; Murono S; Hirano S; Ueda T; Hanai N; Tsukahara K; Ota I; Yoshimoto S; Shinozaki T; Iwae S; Katagiri K; Saito D; Kiyota N; Tahara M; Takahashi F; Hayashi R
    Laryngoscope; 2021 Mar; 131(3):E870-E874. PubMed ID: 33216374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To analyze the impact of intracavitary brachytherapy as boost radiation after external beam radiotherapy in carcinoma of the external auditory canal and middle ear: a retrospective analysis.
    Badakh DK; Grover AH
    J Cancer Res Ther; 2014; 10(2):342-6. PubMed ID: 25022389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments and outcomes of malignant tumors of external auditory canal.
    Chang CH; Shu MT; Lee JC; Leu YS; Chen YC; Lee KS
    Am J Otolaryngol; 2009; 30(1):44-8. PubMed ID: 19027512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superselective, intra-arterial, rapid infusion chemotherapy for external auditory canal carcinoma.
    Ueda Y; Kurita T; Matsuda Y; Ito S; Nakashima T
    J Laryngol Otol Suppl; 2009; (31):75-80. PubMed ID: 19460210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary carcinoma of the external auditory canal and the middle ear. Apropos of 14 cases].
    Bassereau G; Brasnu D; Roux FX; Menard M; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1989; 106(3):169-75. PubMed ID: 2662869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Jun; 133(6):633-40. PubMed ID: 23394224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
    Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
    Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.